March 28, 2023

COVID-19 News: New variant of Omicron does not kill antibodies, new Lancet study reveals

2 min read


Antibodies do not affect the new form of Omicron.
The disclosure has been made in the journal Lancet Infectious Disease.
The SARS-CoV-2 virus enters human cells through a spike protein.

London: According to a recent study, the BA.2.75.2 form of Omicron is not neutralized by antibodies present in the blood and is also not affected by many COVID-19 antibody related treatments. This study is published in the journal Lancet Infectious Disease. According to the findings of researchers from the Karolinska Institute in Sweden, in the winter season SARS-CoV-2 There is a risk of developing infections from the form unless newly developed vaccines help boost people’s immunity.

Study author Ben Murrell, an assistant professor at the Karolinska Institutet, said antibody immunity is not yet completely eradicated, with BA.2.75.2 showing much greater resistance than previously studied forms. SARS-CoV-2 Virus ‘Spike Protein’ Enters human cells through and infects them.

Also read- XBB, the new variant of Corona spread in these countries, created a stir, know how dangerous it is

According to the study, antibodies present in samples taken from 75 blood donors in Stockholm were only one-sixth as effective in neutralizing BA.2.75.2. These samples were taken at three different times. Some samples were taken in November last year when the Omicron form had not been revealed. Some samples were taken in April and some in late August to early September.

Tags:, corona virus research, COVID 19, Omicron variant

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © All rights reserved. | Newsphere by AF themes.